100 Participants Needed

Conversational Data Collection for Chronic Pain

(CADS Trial)

SC
MR
Overseen ByMark Ruchman, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: AugMend Health Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This research study is being conducted to evaluate digital software tools that collect health information through conversations. The study will test how acceptable, feasible, and usable these conversational software programs are for patients with chronic pain.

Purpose of the Study:

The goal is to understand whether digital conversational tools can effectively gather biopsychosocial information (biological, psychological, and social factors related to health) from patients experiencing chronic pain. Biopsychosocial information includes details about your physical symptoms, emotional well-being, social circumstances, and how these factors interact to affect your health. These digital tools are designed to have conversation-like interactions with patients to collect this comprehensive health data in a more natural and engaging way.

What Participation Involves:

If you join this study, you will interact with digital conversational software that will ask you questions about your health, pain experience, and related factors. The software is designed to communicate with you in a conversational manner, similar to talking with a healthcare provider, to gather information about your condition. You will be asked about various aspects of your chronic pain experience, including how it affects your daily life, your emotional state, and your social interactions.

Who Can Participate:

This study is looking for participants who have chronic pain conditions. Medical providers who treat patients with chronic pain are encouraged to refer eligible patients to this study. Healthcare providers interested in referring patients or learning more about the study can contact the study sponsor, AugMend Health Inc.

Why This Research Matters:

Chronic pain affects millions of people and understanding the full scope of how it impacts patients requires collecting detailed information about physical, psychological, and social factors. Traditional methods of collecting this information can be time-consuming and may not capture the complete picture. Digital conversational tools offer a potential new approach to gathering comprehensive health information in a more efficient and patient-friendly manner. This research will evaluate whether patients find these tools acceptable to use, whether they work practically in real-world clinical settings, and whether they are user-friendly and accessible for people with chronic pain.

Study Location:

The study is being conducted at AugMend Health in Cambridge, Massachusetts.

Study Sponsor:

This study is sponsored by AugMend Health Inc. Healthcare providers or potential participants who would like more information about the study or wish to make a referral can contact AugMend Health Inc.

Participation in this study is voluntary, and you can choose to stop participating at any time without affecting your regular medical care.

Who Is on the Research Team?

MR

Mark Ruchman, MD

Principal Investigator

AugMend Health

AT

Alexandra Therond, MA

Principal Investigator

AugMend Health

Are You a Good Fit for This Trial?

This study is for adults over 18 with chronic pain lasting more than 3 months, who can read English and give informed consent. Participants should be able to complete tasks at home or travel to the MIT.nano Immersion Lab if needed, have access to technology for home participation, and be cognitively capable of interacting with digital tools.

Inclusion Criteria

I am 18 years old or older.
I have been experiencing pain for 3 months or more.
I can read and understand English.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Data Collection

Participants interact with digital software to provide biopsychosocial information about their chronic pain condition.

1-2 weeks
Home-based or MIT.nano Immersion Lab sessions

Follow-up

Participants are monitored for usability, feasibility, and acceptability of the digital tools.

1-2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Digital Biopsychosocial Conversational Data Collection Software
  • Standard Digital Questionnaire Data Collection

Trial Overview

The trial is testing conversational software that collects health information from patients by simulating a natural conversation. It aims to see how well these tools gather comprehensive biopsychosocial data in those experiencing chronic pain.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Experimental Digital Biopsychosocial Data Collection SoftwareExperimental Treatment1 Intervention
Group II: Control Standard Data Collection MethodActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

AugMend Health Inc.

Lead Sponsor